Group 1: Zacks Premium and Style Scores Overview - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1] - The Zacks Style Scores rate stocks based on value, growth, and momentum characteristics, serving as complementary indicators to the Zacks Rank [2][3] Group 2: Style Scores Categories - The Value Score focuses on identifying undervalued stocks using ratios like P/E, PEG, and Price/Sales to highlight attractive investment opportunities [3] - The Growth Score emphasizes a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow for sustainable growth [4] - The Momentum Score helps investors capitalize on price trends by assessing one-week price changes and monthly earnings estimate changes [5] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for evaluating stocks based on value, growth, and momentum [6] Group 3: Zacks Rank and Performance - The Zacks Rank is a proprietary model that utilizes earnings estimate revisions to assist investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have achieved an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B to maximize returns [9] Group 4: Stock Highlight - Ventas, Inc. - Ventas, Inc. is a healthcare REIT with investments in 1,406 properties across North America and the U.K. as of March 31, 2025 [11] - Currently rated 3 (Hold) with a VGM Score of B, Ventas has a Momentum Style Score of A, and its shares have increased by 0.6% over the past four weeks [12] - The Zacks Consensus Estimate for Ventas' earnings has risen by $0.02 to $3.45 per share, with an average earnings surprise of 1.2% [12]

Core Insights - American Healthcare REIT, Inc. reported strong performance in Q1 2025, with a Same-Store NOI growth of 15.1% compared to Q1 2024, driven by demand for long-term care and effective expense management [4][8][14] - The company has increased its full-year 2025 guidance for Same-Store NOI growth from a range of 7.0% to 10.0% to a revised range of 9.0% to 13.0% [8][14] - The company has a pipeline of over $300 million in potential acquisitions, indicating a proactive approach to external growth opportunities [6][8] Financial Performance - The company reported a GAAP net loss of $(6.8) million for Q1 2025, with a net loss per diluted share of $(0.04) [8][29] - Normalized Funds from Operations (NFFO) for Q1 2025 were reported at $0.38 per diluted share, reflecting a strong operational performance [8][32] - Total revenues for Q1 2025 increased to $540.6 million from $499.5 million in Q1 2024, primarily due to higher resident fees and services [29][40] Segment Performance - The ISHC segment achieved a Same-Store NOI growth of 19.8%, while the SHOP segment saw a growth of 30.7% in Q1 2025 compared to the same period in 2024 [5][8] - The outpatient medical segment reported a modest Same-Store NOI growth of 2.0%, while the triple-net leased properties experienced a decline of (1.4)% [5][8] Capital Markets and Balance Sheet - As of March 31, 2025, the company's total consolidated indebtedness was $1.67 billion, with a Net Debt-to-Annualized Adjusted EBITDA ratio of 4.5x [11][8] - The company raised approximately $47.7 million through the issuance of 1,577,113 shares of common stock during Q1 2025 [12][8] - The company has approximately $634.5 million in total liquidity, which includes cash, restricted cash, and undrawn capacity on its line of credit [11][8] Development and Transactional Activity - The company initiated two new development projects during Q1 2025, with a total expected cost of approximately $60.0 million [10][8] - A lease buyout in the ISHC segment was completed for approximately $16.1 million, and several non-core properties were sold for a total of approximately $39.0 million [9][8]

Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q1 2025 were $0.75 per share, and funds available for distribution (FAD) were $0.71 per share, reflecting revenue and EBITDA growth [6][11] - Revenue for Q1 2025 was $277 million, up from $243 million in Q1 2024, primarily due to new investments and operator restructurings [10] - Net income for Q1 2025 was $112 million, or $0.33 per share, compared to $69 million, or $0.27 per share, in Q1 2024 [10][11] - NAREIT FFO for Q1 was $184 million, or $0.62 per share, compared to $153 million, or $0.60 per share, in Q1 2024 [11] Business Line Data and Key Metrics Changes - The percentage of private pay and other revenue increased from 8% ten years ago to 39% today, with expectations for continued growth [9] - Maplewood's occupancy for its core portfolio reached 94% as of April 2025, with rent payments improving significantly [20] Market Data and Key Metrics Changes - The trailing twelve-month operator EBITDAR coverage for the core portfolio increased to 1.51x as of December 31, 2024, compared to 1.50x for the previous period [18] - Omega's investment activity in Q1 2025 included over $423 million in new real estate investments and $34 million in CapEx investments [22] Company Strategy and Development Direction - The company raised and narrowed its full-year adjusted FFO guidance to a range between $2.95 to $3.01 per share, assuming no change in revenue related to operators [14] - Omega is focusing on disciplined and sustainable investment decisions while serving a complex resident population across various asset types and markets [19] - The company continues to prioritize capital allocation towards accretive owned real estate deals that grow its balance sheet [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability of Genesis to continue paying rent, despite recent liquidity issues [7][35] - The company remains optimistic about the overall coverage and fundamentals improving, with no significant changes expected in the lending environment [29][63] - Management is closely monitoring potential Medicaid reforms and their implications for the business [29][81] Other Important Information - The company completed a $344 million investment for a portfolio of 45 care homes across the UK and Jersey, with an initial cash yield of 10% [24] - The federal judge ruled in favor of the industry regarding staffing mandates, which is expected to save the federal government $22 billion over ten years [28] Q&A Session Summary Question: Details on Genesis not paying rent and interest in March - Management indicated that Genesis has a weak balance sheet, and the shortfall was a one-time issue related to their ABL lender [34][36] Question: More details on the UK portfolio acquisition - The acquisition involved six operators and was completed quickly due to the company's strong platform in the UK [41][42] Question: Impact of immigration on labor availability and wage pressures - Management has not seen any significant impact from immigration on labor availability or wage pressures at this time [46] Question: Genesis operating fundamentals - Coverage metrics for Genesis have improved, with the portfolio consistently above 1.5 times [47] Question: Cap rates for yields on first quarter dispositions - Management indicated that the dispositions were both opportunistic and part of a cleanup of non-core assets [85]

Core Insights - Welltower Inc. (WELL) reported first-quarter 2025 normalized funds from operations (FFO) per share of $1.20, exceeding the Zacks Consensus Estimate of $1.15, and reflecting an 18.8% year-over-year improvement [1] - The company recorded revenues of $2.42 billion, surpassing the Zacks Consensus Estimate of $2.37 billion, with a year-over-year increase of 30.3% [2] - Welltower increased its guidance for 2025 normalized FFO per share to a range of $4.90-$5.04, up from the previous range of $4.79-$4.95, with the Zacks Consensus Estimate at $4.95 [9] Financial Performance - The same-store revenues in the seniors housing operating (SHO) portfolio increased by 9.6% year over year, supported by a 400 basis points growth in average occupancy and a 5.9% increase in Revenue per Occupied Room (RevPOR) [3] - The total portfolio's same-store net operating income (SSNOI) grew by 12.9% year over year, with the SHO portfolio's SSNOI growth at 21.7% [3] - Property operating expenses rose by 33.3% to $1.46 billion year over year [5] Investment Activities - Welltower's pro-rata gross investments in the first quarter totaled $2.8 billion, including $2.7 billion in acquisitions and loan funding, and $142 million in development funding [4] - The company completed nine development projects with a total pro-rata investment of $475 million and property dispositions of $381 million [4] Balance Sheet and Liquidity - As of March 31, 2025, Welltower had $8.6 billion in available liquidity, which includes $3.6 billion in cash and restricted cash, along with full capacity under its $5 billion line of credit [6] Credit Rating - On March 31, 2025, S&P upgraded Welltower's credit rating to "A-" with a stable outlook, while Moody's upgraded it to "A3" with a stable outlook [7] Dividend Information - Welltower announced a cash dividend of 67 cents per share for the first quarter of 2025, marking the company's 216th consecutive quarterly cash dividend payout [8] Future Guidance - The company anticipates an average blended SSNOI growth of 10.00-13.25% for 2025, with specific growth expectations for various segments [9] - Welltower expects to fund an additional $340 million in development for ongoing projects in 2025 [10]